Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.8021.1713.2110.299.21

What is the latest EV/Core EBITDA ratio of SAKAR HEALTHCARE ?

The latest EV/Core EBITDA ratio of SAKAR HEALTHCARE is 10.80 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202510.80
Mar202421.17
Mar202313.21
Mar202210.29
Mar20219.21

How is EV/Core EBITDA of SAKAR HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2025 10.8
-48.98
Mar2024 21.17
60.26
Mar2023 13.21
28.38
Mar2022 10.29
11.73
Mar2021 9.21 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare EV/Core EBITDA ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹1,852.8 Cr 6.1% 32.9% 165.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,469.0 Cr -2.8% -1% 6.7% Stock Analytics
DIVIS LABORATORIES ₹173,305.0 Cr -3.3% 0.4% -2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,014.0 Cr -3.1% 2.9% 36.9% Stock Analytics
CIPLA ₹111,388.0 Cr -2.7% 5.3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,381.0 Cr -4.1% -3.7% 3.7% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

6.1%

32.9%

165.9%

SENSEX

-2.4%

-3.7%

-9.2%


You may also like the below Video Courses